ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,713.64
      0.00%
      US Tech 100
      19,317.20
      -0.09%
      Dow Jones
      42,025.19
      0.00%
      Brent Oil
      73.845
      -0.64%
      Bitcoin
      63,406.59
      0.73%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Neurocrine Biosciences Inc (NBIX)

      7. Neurocrine Biosciences Inc (NBIX) Financials

      Neurocrine Biosciences Inc

      Neurocrine Biosciences Inc (NBIX)

      NASDAQ
      120.46
      0.61
      (0.51%)
      Closed September 19 4:00PM
      Delayed by 15 minutes
      120.46
      0.00
      ( 0.00% )
      Pre Market: 7:00AM
      Delayed by 15 minutes

      Neurocrine Biosciences Inc Financial Summary

      The current NBIX market cap is 12.16B. The company's latest EPS is USD 2.4729 and P/E is 48.71.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 452.7M498.8M515.2M515.3M590.2M
      Operating Income 73.6M141.2M150.3M99.3M145.4M
      Net Income 95.5M83.1M147.7M43.4M65M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 788.09M1.05B1.13B1.49B1.89B
      Operating Income 72.28M163M102.5M249M250.9M
      Net Income 37.01M407.3M89.6M154.5M249.7M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 2.61B2.85B3.25B3.47B3.31B
      Total Liabilities 760.1M846.1M1.02B1.09B795.8M
      Total Equity 1.85B2B2.23B2.39B2.51B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.31B1.73B2.07B2.37B3.25B
      Total Liabilities 669.12M608.5M698.5M660.9M1.02B
      Total Equity 636.92M1.13B1.37B1.71B2.23B

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 54.4M266.4M389.9M130.3M194.9M
      Investing -168M-265.3M-467.1M-55M-83.2M
      Financing 11.1M29.9M65.3M69.9M-223.1M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 152.05M228.5M256.5M339.4M389.9M
      Investing -211.07M4.1M-130.2M-177.1M-467.1M
      Financing 27.31M-157.8M27.4M-234.3M65.3M

      Stats and Ratios

      Market Cap 12.16B
      Price to Earnings Ratio 48.71
      Price to Sales Ratio 6.45
      Price to Cash Ratio 48.44
      Price to Book Ratio 5.45
      Dividend Yield -

      Share Statistics

      Shares Outstanding 100.98M
      Average Volume (1 week) 835.42k
      Average Volume (1 Month) 1.19M
      52 Week Change 5.03%
      52 Week High 157.9799
      52 Week Low 103.63
      Spread (Intraday) 10.62 (8.49%)

      Company Info

      Company Name Neurocrine Biosciences Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.neurocrine.com
      Industry biological pds,ex diagnstics (2836)

      Your Recent History

      NASDAQ
      NBIX
      Neurocrine Biosciences
      Delayed Upgrade Clock